In 180 symptomatic patients with coronary artery disease and CAC scores of 50–400 AU, menaquinone-7 360 µg daily for 2 years slowed coronary calcification vs placebo (median CAC 135→184 vs 145→214 AU; P = .02); no significant adverse effects.
RCTn = 180
Vossen et al. Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial